133 related articles for article (PubMed ID: 8775464)
1. The structure of MHC class II: a role for dimer of dimers.
Schafer PH; Pierce SK; Jardetzky TS
Semin Immunol; 1995 Dec; 7(6):389-98. PubMed ID: 8775464
[TBL] [Abstract][Full Text] [Related]
2. The assembly and stability of MHC class II-(alpha beta)2 superdimers.
Schafer PH; Malapati S; Hanfelt KK; Pierce SK
J Immunol; 1998 Sep; 161(5):2307-16. PubMed ID: 9725225
[TBL] [Abstract][Full Text] [Related]
3. TCR-induced transmembrane signaling by peptide/MHC class II via associated Ig-alpha/beta dimers.
Lang P; Stolpa JC; Freiberg BA; Crawford F; Kappler J; Kupfer A; Cambier JC
Science; 2001 Feb; 291(5508):1537-40. PubMed ID: 11222857
[TBL] [Abstract][Full Text] [Related]
4. Molecular associations and microdomains in antigen-presenting cell-T-cell interactions.
Triantafilou K; Triantafilou M; Fernandez N
Crit Rev Immunol; 2000; 20(5):359-73. PubMed ID: 11145215
[TBL] [Abstract][Full Text] [Related]
5. Function and regulation of MHC class II molecules in T-lymphocytes: of mice and men.
Holling TM; Schooten E; van Den Elsen PJ
Hum Immunol; 2004 Apr; 65(4):282-90. PubMed ID: 15120183
[TBL] [Abstract][Full Text] [Related]
6. The role of L3T4 in T cell activation: L3T4 may be both an Ia-binding protein and a receptor that transduces a negative signal.
Tite JP; Sloan A; Janeway CA
J Mol Cell Immunol; 1986; 2(4):179-90. PubMed ID: 3509916
[TBL] [Abstract][Full Text] [Related]
7. Length and sequence requirements of the cytoplasmic domain of the A beta molecule for class II-mediated B cell signaling.
Harton JA; Bishop GA
J Immunol; 1993 Nov; 151(10):5282-9. PubMed ID: 8228224
[TBL] [Abstract][Full Text] [Related]
8. Structural principles of MHC class II antigen presentation.
Nelson CA; Fremont DH
Rev Immunogenet; 1999; 1(1):47-59. PubMed ID: 11256572
[TBL] [Abstract][Full Text] [Related]
9. CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T cells.
Lapointe R; Bellemare-Pelletier A; Housseau F; Thibodeau J; Hwu P
Cancer Res; 2003 Jun; 63(11):2836-43. PubMed ID: 12782589
[TBL] [Abstract][Full Text] [Related]
10. Envelope glycoproteins of HIV-1 interfere with T-cell-dependent B cell differentiation: role of CD4-MHC class II interaction in the effector phase of T cell help.
Chirmule N; Wang XP; Hu R; Oyaizu N; Roifman C; Pahwa R; Kalyanaraman VS; Pahwa S
Cell Immunol; 1994 Apr; 155(1):169-82. PubMed ID: 8168144
[TBL] [Abstract][Full Text] [Related]
11. MHC class II antigen presentation pathway in murine tumours: tumour evasion from immunosurveillance?
Walter W; Lingnau K; Schmitt E; Loos M; Maeurer MJ
Br J Cancer; 2000 Nov; 83(9):1192-201. PubMed ID: 11027433
[TBL] [Abstract][Full Text] [Related]
12. The MHC class II-associated invariant chain: a molecule with multiple roles in MHC class II biosynthesis and antigen presentation to CD4+ T cells.
Bertolino P; Rabourdin-Combe C
Crit Rev Immunol; 1996; 16(4):359-79. PubMed ID: 8954255
[TBL] [Abstract][Full Text] [Related]
13. Polarized transport of MHC class II molecules in Madin-Darby canine kidney cells is directed by a leucine-based signal in the cytoplasmic tail of the beta-chain.
Simonsen A; Pedersen KW; Nordeng TW; von der Lippe A; Stang E; Long EO; Bakke O
J Immunol; 1999 Sep; 163(5):2540-8. PubMed ID: 10452991
[TBL] [Abstract][Full Text] [Related]
14. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
Bodey B; Bodey B; Kaiser HE
In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
[TBL] [Abstract][Full Text] [Related]
15. Development of an I-Ag7-expressing antigen-presenting cell line: intrinsic molecular defect in compact I-Ag7 dimer generation.
Nabavieh A; Chou H; Volokhov I; Lee JE; Purdy LE; Elliott JF; Singh B; Madrenas J
J Autoimmun; 1998 Feb; 11(1):63-71. PubMed ID: 9480724
[TBL] [Abstract][Full Text] [Related]
16. Intercellular adhesion molecule-1 and leukocyte function-associated antigen-3 provide costimulation for superantigen-induced T lymphocyte proliferation in the absence of a specific presenting molecule.
Lamphear JG; Stevens KR; Rich RR
J Immunol; 1998 Jan; 160(2):615-23. PubMed ID: 9551895
[TBL] [Abstract][Full Text] [Related]
17. MHC class II proteins contain a potential binding site for the verotoxin receptor glycolipid CD77.
George T; Boyd B; Price M; Lingwood C; Maloney M
Cell Mol Biol (Noisy-le-grand); 2001 Nov; 47(7):1179-85. PubMed ID: 11838965
[TBL] [Abstract][Full Text] [Related]
18. CD83 influences cell-surface MHC class II expression on B cells and other antigen-presenting cells.
Kuwano Y; Prazma CM; Yazawa N; Watanabe R; Ishiura N; Kumanogoh A; Okochi H; Tamaki K; Fujimoto M; Tedder TF
Int Immunol; 2007 Aug; 19(8):977-92. PubMed ID: 17804692
[TBL] [Abstract][Full Text] [Related]
19. [MHC tetramers: tracking specific immunity].
Kosor E; Gagro A; Drazenović V; Kuzman I; Jeren T; Rakusić S; Rabatić S; Markotić A; Gotovac K; Sabioncello A; Cecuk E; Kerhin-Brkljacić V; Gjenero-Margan I; Kaić B; Mlinarić-Galinović G; Kastelan A; Dekaris D
Acta Med Croatica; 2003; 57(4):255-9. PubMed ID: 14639858
[TBL] [Abstract][Full Text] [Related]
20. Mixed-haplotype MHC class II molecules select functional CD4+ T cells.
Silk JD; Schoendorf D; Bartok I; Chai JG; Gray D; Simpson E; Dyson J
Mol Immunol; 2005 Jun; 42(10):1129-39. PubMed ID: 15829303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
